Literature DB >> 23877478

Unique cerebrovascular anomalies in Noonan syndrome with RAF1 mutation.

Yuri A Zarate1, Angie W Lichty2, Kristen J Champion2, L Kate Clarkson2, Kenton R Holden3, M Gisele Matheus4.   

Abstract

Noonan syndrome is a common autosomal dominant neurodevelopmental disorder caused by gain-of-function germline mutations affecting components of the Ras-MAPK pathway. The authors present the case of a 6-year-old male with Noonan syndrome, Chiari malformation type I, shunted benign external hydrocephalus in infancy, and unique cerebrovascular changes. A de novo heterozygous change in the RAF1 gene was identified. The patient underwent brain magnetic resonance imaging, computed tomography angiography, and magnetic resonance angiography to further clarify the nature of his abnormal brain vasculature. The authors compared his findings to the few cases of Noonan syndrome reported with cerebrovascular pathology.
© The Author(s) 2013.

Entities:  

Keywords:  Noonan syndrome; cerebrovascular circulation; mutation

Mesh:

Substances:

Year:  2013        PMID: 23877478     DOI: 10.1177/0883073813492384

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  6 in total

1.  A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair.

Authors:  Karen W Gripp; Kimberly A Aldinger; James T Bennett; Laura Baker; Jessica Tusi; Nina Powell-Hamilton; Deborah Stabley; Katia Sol-Church; Andrew E Timms; William B Dobyns
Journal:  Am J Med Genet A       Date:  2016-06-05       Impact factor: 2.802

Review 2.  Attention deficit hyperactivity disorder (ADHD) in phenotypically similar neurogenetic conditions: Turner syndrome and the RASopathies.

Authors:  Tamar Green; Paige E Naylor; William Davies
Journal:  J Neurodev Disord       Date:  2017-07-10       Impact factor: 4.025

3.  Clinical profile of comorbidity of rare diseases in a Tunisian patient: a case report associating incontinentia pigmenti and Noonan syndrome.

Authors:  Nehla Ghedira; Arnaud Lagarde; Karim Ben Ameur; Sahar Elouej; Rania Sakka; Emna Kerkeni; Fatma-Zohra Chioukh; Sylviane Olschwang; Jean-Pierre Desvignes; Sonia Abdelhak; Valerie Delague; Nicolas Lévy; Kamel Monastiri; Annachiara De Sandre-Giovannoli
Journal:  BMC Pediatr       Date:  2018-08-29       Impact factor: 2.125

4.  Endovascular management of spontaneous intracranial pseudoaneurysms in a pediatric patient with Noonan syndrome. A mere coincidence or a possible association with the disorder?

Authors:  Sofia Athanasiou; Christina Aslanidi; Vasileios Mamalis; George Markogiannakis; Antonios Tsanis; Eftichios Arhontakis
Journal:  Surg Neurol Int       Date:  2021-10-25

5.  Noonan syndrome with RAF1 gene mutations in a newborn with cerebral haemorrhage.

Authors:  Junwei Lan; Tianbao Zeng; Sheng Liu; Juhong Lan; Lijun Qian
Journal:  Eur J Med Res       Date:  2022-08-11       Impact factor: 4.981

6.  MEK Inhibition in a Newborn with RAF1-Associated Noonan Syndrome Ameliorates Hypertrophic Cardiomyopathy but Is Insufficient to Revert Pulmonary Vascular Disease.

Authors:  Alessandro Mussa; Diana Carli; Elisa Giorgio; Anna Maria Villar; Simona Cardaropoli; Caterina Carbonara; Maria Francesca Campagnoli; Paolo Galletto; Martina Palumbo; Simone Olivieri; Claudio Isella; Gregor Andelfinger; Marco Tartaglia; Giovanni Botta; Alfredo Brusco; Enzo Medico; Giovanni Battista Ferrero
Journal:  Genes (Basel)       Date:  2021-12-21       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.